Rio Health Raises $4.5M for Pharmacy Network Expansion

Rio Health, a fast-growing player in the pharmaceutical quick commerce space, has successfully closed a $4.5 million pre-Series A funding round. The investment, spearheaded by Version One Ventures, with significant participation from existing backers Xeed Ventures, Good Capital, and Amplify, signals strong confidence in the company's model for delivering medicines and health essentials with remarkable speed.

This capital infusion is earmarked for aggressive expansion within the Delhi NCR region. Rio Health plans to establish an additional 12 dark stores, strategically positioning them to enhance delivery efficiency. Beyond physical infrastructure, the funding will bolster the startup's technological backbone, focusing on optimizing ordering systems, inventory management, and last-mile delivery logistics. The company is ambitiously targeting an annual recurring revenue (ARR) exceeding ₹150 crore within the next nine to twelve months.

Founded in 2024 by Ankur Agrawal and Amit Ahuja, Rio Health differentiates itself by promising delivery of medications and healthcare necessities in under 30 minutes across Delhi NCR. The platform accommodates orders via text, voice, or prescription uploads, supporting English, Hindi, and Hinglish. An AI-driven system identifies prescribed medicines, streamlining the order process, which is then finalized by a licensed pharmacist, addressing the critical regulatory requirements of pharmaceutical distribution.

The operational efficiency is evident in the startup's current metrics: processing over 30,000 orders monthly with an average order value ranging from ₹600 to ₹700. A key indicator of customer satisfaction and loyalty is the reported 80% repeat customer rate. Rio Health currently manages an inventory of over 20,000 SKUs, with a robust distributor network in place to source less common medications. Its dark store model operates within a 3-kilometer radius, leveraging localized demand data to ensure optimal stock levels.

This funding round brings Rio Health's total raised capital to approximately ₹62.2 crore ($6.5 million), following previous investments totaling ₹19.2 crore. The company's growth trajectory aligns with the broader surge in quick commerce, a sector projected to reach between $30 billion and $40 billion in India over the next five years. While giants like Zepto, Blinkit, and Swiggy Instamart are exploring rapid pharmaceutical delivery, the inherent complexities—including licensing, prescription verification, and stringent storage protocols—create a distinct opportunity for specialized operators like Rio Health.

The specialized pharmacy delivery segment is attracting significant investor attention. For instance, Plazza, another tech-enabled neighborhood pharmacy, secured $15 million in July 2026 to enhance its AI-driven inventory systems and expand its footprint. Rio Health's strategic focus on rapid, reliable, and compliant medicine delivery positions it to capture a substantial share of this evolving market, navigating the unique challenges and immense potential of health-focused quick commerce.